Design Therapeutics Inc (DSGN) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Design Therapeutics Inc   (NASDAQ: DSGN)


Design Therapeutics Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Design Therapeutics Inc 's ROA in the third quarter of 2026?
Design Therapeutics Inc recorded a cumulative net loss of $-74 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -27.45%.

However, within the Healthcare sector 436 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3683, from total ROA ranking in the second quarter of 2026 at 4323.

What is ROA?



Return On Assets (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 3.38 % 85.37 % -3.45 % -10.26 % -19.12 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -74 -71 -70 -70 -67
Return On Assets (TTM) -27.45 % -26.4 % -31.55 % -31.3 % -29.4 %
DSGN's Total Ranking # 3683 # 4323 # 3774 # 3729 # 3691
Total Assets (TTM) in million 217 410 228 225 210
Seq. Total Assets Change -46.98 % 79.82 % 1.38 % 6.96 % -4.94 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 169
Sector # 437
Overall # 3664

Return On Assets Statistics
High Average Low
-8.84 %
-20.95 %
-32.05 %
(Dec 31 2021)   (Jun 30 2026)





Financial Statements
Design Therapeutics Inc 's Assets $ 217 million DSGN's Balance sheet
Design Therapeutics Inc 's Income $ -20 million Quarterly DSGN's Income Statement
DSGN's Income by Division See DSGN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change -10.26 % -13.12 % -14.98 % -12.37 % -
Total Assets in million 225 250 288 339 387
Y / Y Net Income Change - - - - -
Net Income in million -70 -50 -67 -63 -36
Annual Return On Assets -31.05 % -19.8 % -23.19 % -18.67 % -9.18 %




More Return On Assets Ratios
DSGN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DSGN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DSGN's Competitors
Subscribers only: Roa for Design Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DSGN's Customers

You may also want to know
DSGN's Roi DSGN's Inventory Turnover Ratio DSGN's Growth Rates DSGN's Dividend Comparisons
DSGN's Profitability Ratios DSGN's Asset Turnover Ratio DSGN's Dividend Growth
DSGN's Roe DSGN's Valuation Ratios DSGN's Financial Strength Ratios DSGN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA


Date modified: 2026-11-05T09:47:47+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.